Parkure is a Scottish company with the mission of finding a cure for Parkinson’s disease. Our highly qualified scientific and business team are committed to translating current scientific knowledge into treatments that stop the brain degeneration process of Parkinson’s disease.
Parkure has been founded to try to solve a problem. The problem is that, despite many scientific advances, there is still no sign of a cure for Parkinson’s disease. What do we mean by a cure? A cure is a treatment that stops the nerve cell degeneration process in its tracks.
Why is there this problem? The biology of Parkinson’s disease is complex, so that the well-established protein target-based drug development approaches used by industry have not worked so far.
Parkure is taking a different approach – to use a brain affected by Parkinson’s disease to test treatments.
Parkure is unique as a company in both its commitment to finding a cure for Parkinson’s disease and the way we are going about it.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 10-15 George Square, Edinburgh,eh8 9xd,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- parkure.co.uk
- HQ
- Edinburgh
Parkure Questions
Parkure's website is parkure.co.uk
Parkure's LinkedIn profile is https://uk.linkedin.com/company/parkure
Parkure has
3 employees.
View email and phone details for 3
employees at Parkure.
Parkure's industry is
Biotechnology Research
Parkure's top competitors are
Caldan Therapeutics,
Ilc Therapeutics,
Sifi Labs,
Altacor,
Aten Therapeutics Ltd,
Avipero,
Macomics,
Ocuvex Therapeutics,
Neurocentrx Pharma Ltd.,
Mironid® Limited.
Parkure's categories are Biotechnology Research
Parkure's founding year is 2014
